Latest News Releases
Thanks to funding support from GIVEHOPE and BSI Engineering, Inc., scientistsat UC can continue research that could help better treat pancreatic cancerpatients.
Jianjun Chen, PhD, received a $550,000 Leukemia and Lymphoma Society ScholarAward to support research looking at the role of TET1 protein in acute myeloidleukemia.
The UC Cancer Institute is hosting a free educational event surroundingpancreatic cancer for patients, survivors, their families and the community.
To say Ft. Mitchell, Kentucky resident Doug Lange, 63, is always on the go isan understatement.
Troy Witt, 65, a London, Kentucky resident, completed treatment at theCincinnati Children's/UC Health Proton Therapy Center in Fall 2016. Now, he'sback to enjoying life.
Researchers at the University of Cincinnati (UC) have received $2.4 million infederal funding to pursue research on a novel cell therapy that would repairheart damage using modified cells taken from the patient's own facial muscle.
Four of six cancer cluster hires were celebrated in an event where leadershipfrom each of the involved colleges spoke about the momentum of this initiativemoving forward.
A clinical trial hosted at the is looking at ways proton radiation couldimprove outcomes and quality of life for patients with anal cancer.
Cancer researchers have found an obesity-associated protein's role in leukemiadevelopment and drug response which could lead to more effective therapies forthe illness.
UC researchers have been able to generate multifunctional RNA nanoparticlesthat could overcome treatment resistance in breast cancer, making existingtreatments effective.
More News >>